- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT04892173
NBTXR3 med eller utan Cetuximab i LA-HNSCC
En fas 3-studie av NBTXR3 aktiverad av utredarens val av strålbehandling ensam eller strålbehandling i kombination med Cetuximab för platinabaserad kemoterapi-oberättigade äldre patienter med LA-HNSCC
This is a global, open-label, randomized, 2-arm, Investigator's choice Phase 3 (Pivotal Stage) study to investigate the efficacy and safety of JNJ-90301900 (NBTXR3) / radiation therapy (RT)±cetuximab versus RT±cetuximab in treatment-naïve, platinum-ineligible, elderly participants with locally advanced head and neck squamous cell carcinoma (LA-HNSCC).
Studieöversikt
Status
Betingelser
Intervention / Behandling
Studietyp
Inskrivning (Beräknad)
Fas
- Fas 3
Kontakter och platser
Studiekontakt
- Namn: Study Contact
- Telefonnummer: 844-434-4210
- E-post: Participate-In-This-Study1@its.jnj.com
Studieorter
-
-
-
Brussels, Belgien, 1200
- Rekrytering
- Cliniques Universitaires Saint Luc
-
Charleroi, Belgien, 6060
- Avslutad
- Grand Hopital De Charleroi Site Les Viviers
-
Leuven, Belgien, 3000
- Rekrytering
- Universitair Ziekenhuis Leuven
-
-
-
-
-
Barretos, Brasilien, 14784-400
- Rekrytering
- Fundacao Pio XII
-
Belo Horizonte, Brasilien, 30380 472
- Rekrytering
- Nucleo de Ensino e Pesquisa do Instituto Mario Penna
-
Fortaleza, Brasilien, 60336 232
- Avslutad
- Centro Regional Integrado de Oncologia CRIO
-
Fortaleza, Brasilien, 60430-230
- Rekrytering
- Instituto Do Cancer Do Ceara
-
Ipatinga, Brasilien, 35160 158
- Rekrytering
- Fundacao Sao Francisco Xavier
-
Jaú, Brasilien, 17210 080
- Rekrytering
- Fundacao Doutor Amaral Carvalho
-
Londrina, Brasilien, 86015 520
- Rekrytering
- Hospital do Cancer de Londrina
-
Porto Alegre, Brasilien, 90610-000
- Rekrytering
- Uniao Brasileira de Educacao e Assistencia Hospital Sao Lucas da PUCRS
-
Porto Alegre, Brasilien, 91350-200
- Avslutad
- Hospital Nossa Senhora da Conceicao
-
Porto Alegre, Brasilien, 90050 170
- Rekrytering
- Irmandade Santa Casa de Misericordia de Porto Alegre
-
Rio de Janeiro, Brasilien, 22 250 905
- Rekrytering
- Oncoclinicas Rio de Janeiro S A
-
Salvador, Brasilien, 41950 640
- Rekrytering
- Ensino e Terapia de Inovacao Clinica AMO Etica
-
São José do Rio Preto, Brasilien, 15090-000
- Rekrytering
- Funfarme Sjrp
-
São Paulo, Brasilien, 01246 000
- Rekrytering
- Fundacao Faculdade de Medicina - Instituto do Cancer do Estado de Sao Paulo
-
São Paulo, Brasilien, 01308 050
- Rekrytering
- Sociedade Beneficente de Senhoras Hospital Sirio Libanes
-
Vitória, Brasilien, 29043 260
- Rekrytering
- Associacao Feminina de Educacao e Combate ao Cancer Hospital Santa Rita de Cassia
-
-
-
-
-
Panagyurishte, Bulgarien, 4500
- Avslutad
- MHAT Uni Hospital
-
Sofia, Bulgarien, 1756
- Avslutad
- Specialized Hospital for Active Treatment in Oncology
-
-
-
-
-
Las Piñas, Filippinerna, 1742
- Avslutad
- University of Perpetual Help Dalta Medical Center, Inc
-
Manila, Filippinerna, 1000
- Avslutad
- Manila Doctors Hospital
-
Pasig, Filippinerna, 1600
- Aktiv, inte rekryterande
- The Medical City
-
Quezon City, Filippinerna, 1112
- Avslutad
- St. Luke's Medical Center
-
-
-
-
-
Tampere, Finland, 33520
- Avslutad
- Tampereen Yliopistollinen Sairaala
-
-
-
-
-
Amiens, Frankrike, 80000
- Rekrytering
- CHU Amiens Picardie
-
Brest, Frankrike, 29609
- Rekrytering
- CHU Brest
-
Caen, Frankrike, 14076
- Rekrytering
- Centre Francois Baclesse
-
Dijon, Frankrike, 21000
- Rekrytering
- Centre Georges Francois Leclerc
-
Lille, Frankrike, 59020
- Rekrytering
- Centre de Lutte contre le Cancer Centre Oscar Lambret
-
Lyon, Frankrike, 69008
- Avslutad
- Centre Leon Berard
-
Marseille, Frankrike, 13385
- Rekrytering
- Hopital de la Timone
-
Neuilly-sur-Seine, Frankrike, 92200
- Avslutad
- Clinique Ambroise Pare
-
Paris, Frankrike, 75248
- Rekrytering
- Institut Curie
-
Paris, Frankrike, 75015
- Rekrytering
- Hopital Europeen Georges Pompidou
-
Paris, Frankrike, 75970
- Rekrytering
- Hopital Tenon
-
Pessac, Frankrike, 33604
- Rekrytering
- Hopital Haut Leveque
-
Rennes, Frankrike, 35000
- Rekrytering
- Hopital Pontchaillou
-
Rouen, Frankrike, 76038
- Rekrytering
- CLCC - Centre Henri Becquerel
-
Saint-Etienne, Frankrike, 42055
- Rekrytering
- CHU Saint Etienne
-
Valenciennes, Frankrike, 59322
- Avslutad
- Centre Hospitalier de Valenciennes Hopital Jean Bernard
-
Vandœuvre-lès-Nancy, Frankrike, 54500
- Rekrytering
- Institut de Cancerologie de Lorraine
-
Villejuif, Frankrike, 94805
- Rekrytering
- Gustave Roussy
-
-
-
-
Alabama
-
Birmingham, Alabama, Förenta staterna, 35294
- Rekrytering
- University of Alabama at Birmingham
-
-
California
-
Duarte, California, Förenta staterna, 91010
- Rekrytering
- City of Hope
-
La Jolla, California, Förenta staterna, 92093
- Rekrytering
- University of California at San Diego Moores Cancer Center
-
Laguna Hills, California, Förenta staterna, 92653
- Avslutad
- Memorial Radiation Oncology Medical Group Laguna Hills
-
Los Angeles, California, Förenta staterna, 90095
- Rekrytering
- UCLA Hematology Oncology
-
Newport Beach, California, Förenta staterna, 92663
- Avslutad
- Hoag Memorial Hospital
-
San Francisco, California, Förenta staterna, 94158
- Rekrytering
- University of California San Francisco
-
-
District of Columbia
-
Washington D.C., District of Columbia, Förenta staterna, 20052
- Rekrytering
- George Washington University Cancer Center
-
-
Florida
-
Jacksonville, Florida, Förenta staterna, 32224
- Rekrytering
- Mayo Clinic Jacksonville
-
Orlando, Florida, Förenta staterna, 32803
- Rekrytering
- AdventHealth Orlando
-
Tampa, Florida, Förenta staterna, 33612
- Rekrytering
- Moffitt Cancer Center
-
-
Georgia
-
Atlanta, Georgia, Förenta staterna, 30308
- Rekrytering
- Emory University Hospital Midtown
-
-
Kentucky
-
Lexington, Kentucky, Förenta staterna, 40536
- Rekrytering
- University of Kentucky Markey Cancer Center
-
-
Massachusetts
-
Boston, Massachusetts, Förenta staterna, 02118
- Rekrytering
- Boston Medical Center
-
-
New Mexico
-
Santa Fe, New Mexico, Förenta staterna, 87505
- Avslutad
- Christus St. Vincent Regional Cancer Center
-
-
New York
-
New York, New York, Förenta staterna, 10032
- Avslutad
- Herbert Irving Comprehensive Cancer Center Columbia University Medical Center
-
Staten Island, New York, Förenta staterna, 10310
- Rekrytering
- Richmond University Medical Center
-
The Bronx, New York, Förenta staterna, 10467
- Rekrytering
- Montefiore Medical Center
-
-
North Carolina
-
Chapel Hill, North Carolina, Förenta staterna, 27514
- Rekrytering
- University of North Carolina at Chapel Hill
-
Charlotte, North Carolina, Förenta staterna, 28204
- Rekrytering
- Atrium Health Levine Cancer Institute
-
-
Ohio
-
Cincinnati, Ohio, Förenta staterna, 45219
- Rekrytering
- University of Cincinnati
-
-
Oklahoma
-
Oklahoma City, Oklahoma, Förenta staterna, 73104
- Rekrytering
- Stephenson Cancer Center
-
-
Oregon
-
Portland, Oregon, Förenta staterna, 97239
- Rekrytering
- Oregon Health And Science University
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, Förenta staterna, 19104
- Rekrytering
- University of Pennsylvania Perelman Center for Advanced Medicine
-
-
Virginia
-
Charlottesville, Virginia, Förenta staterna, 22908
- Rekrytering
- University of Virginia
-
Norfolk, Virginia, Förenta staterna, 23507
- Rekrytering
- Macon Joan Brock Virginia Health Sciences Eastern Virginia Medical Group at Old Dominion University
-
-
-
-
-
Batumi, Georgien, 6000
- Rekrytering
- High Technology Hospital MedCenter Ltd Batumi
-
Kutaisi, Georgien, 4600
- Rekrytering
- JSC Vian Kutaisi Referral Hospital
-
Tbilisi, Georgien, 0112
- Avslutad
- Todua Clinic
-
Tbilisi, Georgien, 144
- Rekrytering
- Ltd Tbilisi State Medical University and Ingorokva High Medical Technology University Clinic
-
-
-
-
-
Athens, Grekland, 124 62
- Rekrytering
- University General Hospital Attikon General Hospital Of West Attica H Agia Varvara
-
Larissa, Grekland, 41110
- Rekrytering
- University Hospital Of Larissa
-
Thessaloniki, Grekland, 57001
- Avslutad
- Interbalkan Medical Center of Thessaloniki
-
Thessaloniki, Grekland, 54639
- Rekrytering
- Athens Medical Center S A Interbalkan Medical Center of Thessaloniki
-
-
-
-
-
Bangalore, Indien, 560054
- Rekrytering
- M S Ramaiah Memorial Hospital
-
Chennai, Indien, 600035
- Avslutad
- Apollo Speciality Hospital, Chennai
-
Madurai, Indien, 625107
- Avslutad
- Meenakshi Mission Hospital and Research Center
-
Mumbai, Indien, 400012
- Rekrytering
- Tata Memorial Hospital
-
Nashik, Indien, 422002
- Rekrytering
- HealthCare Global HCG Manavata Cancer Centre
-
New Delhi, Indien, 110085
- Rekrytering
- Rajiv Gandhi Cancer Institute and Research Centre
-
Pune, Indien, 411 001
- Avslutad
- Grant Medical foundation Ruby Hall Clinic
-
Vijayawada, Indien, 520002
- Rekrytering
- HCG cancer center
-
-
-
-
-
Ashdod, Israel, 7747629
- Aktiv, inte rekryterande
- Samson Assuta Ashdod University Hospital
-
Haifa, Israel, 3109601
- Avslutad
- Rambam Health Care Campus
-
Jerusalem, Israel, 9112001
- Avslutad
- Hadassah Medical Center
-
Tel Aviv, Israel, 6423906
- Avslutad
- Tel Aviv Sourasky Medical Center
-
-
-
-
-
Bunkyō City, Japan, 113-8519
- Rekrytering
- Tokyo Medical and Dental University Hospital
-
Hiroshima, Japan, 734 8551
- Rekrytering
- Hiroshima University Hospital
-
Kashiwa, Japan, 277-8577
- Rekrytering
- National Cancer Center Hospital East
-
Nagoya, Japan, 464-8681
- Rekrytering
- Aichi Cancer Center
-
Osaka, Japan, 541 8567
- Rekrytering
- Osaka International Cancer Institute
-
Osaka Sayama Shi, Japan, 589 8511
- Avslutad
- Kindai University Hospital
-
Sendai, Japan, 980 8574
- Rekrytering
- Tohoku University Hospital
-
Shimotsuke, Japan, 329-0498
- Rekrytering
- Jichi Medical University Hospital
-
Shinjuku, Japan, 160 0023
- Rekrytering
- Tokyo Medical University Hospital
-
Sunto Gun, Japan, 411 8777
- Rekrytering
- Shizuoka Cancer Center
-
-
-
-
Ontario
-
Toronto, Ontario, Kanada, M4N 3M5
- Rekrytering
- Sunnybrook Health Sciences Center
-
-
-
-
-
Bengbu, Kina, 233004
- Avslutad
- The Affiliated Hospital of Bengbu Medical College
-
Changsha, Kina, 410008
- Avslutad
- Xiangya Hospital Central South University
-
Changsha, Kina, 410013
- Rekrytering
- Hunan Cancer hospital
-
Chengdu, Kina, 610041
- Rekrytering
- Sichuan Cancer Hospital
-
Dongguan, Kina, 523109
- Rekrytering
- Dongguan People s Hospital
-
Fuzhou, Kina, 350005
- Rekrytering
- The First Affiliated Hospital of Fujian Medical University
-
Fuzhou, Kina, 350001
- Avslutad
- Fujian Medical University Union Hospital
-
Fuzhou, Kina, 350014
- Rekrytering
- Fujian Medical University Fujian Provincial Cancer Hospital
-
Guangzhou, Kina, 510180
- Rekrytering
- Guangzhou First Municipal People's Hospital
-
Guangzhou, Kina, 510080
- Rekrytering
- The First Affiliated Hospital of Guangdong Pharmaceutical University
-
Guangzhou, Kina, 510095
- Rekrytering
- Guangzhou Medical University Affiliated Oncology Hospital
-
Jinan, Kina, 250012
- Rekrytering
- Qilu Hospital of Shandong University
-
Jinan, Kina, 250117
- Rekrytering
- Shandong Cancer Hospital
-
Linyi, Kina, 276002
- Rekrytering
- Linyi Cancer Hospital
-
Liuzhou, Kina, 545006
- Rekrytering
- Liuzhou people's Hospital
-
Nanchang, Kina, 330029
- Avslutad
- Jiangxi Cancer Hospital
-
Nanjing, Kina, 223800
- Rekrytering
- Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School
-
Nanjing, Kina, 210009
- Avslutad
- Jiangsu Cancer Hospital
-
Nanning, Kina, 530000
- Rekrytering
- Wuming Hospital of Guangxi Medical University
-
Nanning, Kina, 530021
- Rekrytering
- The Cancer Hospital Affiliated to Guangxi Medical University
-
Qingdao, Kina, 266003
- Rekrytering
- The Affiliated Hospital of Medical College Qingdao University
-
Shanghai, Kina, 200032
- Avslutad
- Fudan University Shanghai Cancer Center
-
Shenyang, Kina, 110042
- Avslutad
- Liaoning Cancer Hospital and Institute
-
Shenzhen, Kina, 518036
- Rekrytering
- Peking University Shenzhen Hospital
-
Shijiazhuang, Kina, 50011
- Rekrytering
- The Fourth Hospital of Hebei Medical University
-
Suzhou, Kina, 215004
- Avslutad
- Second Affiliated Hospital, SooChow University
-
Taiyuan, Kina, 30013
- Avslutad
- Shanxi Provincial Cancer hospital
-
Tianjin, Kina, 300060
- Avslutad
- Tianjin Medical University Cancer Institute and Hospital
-
Wuhan, Kina, 430022
- Rekrytering
- Union Hospital Tongji Medical College of Huazhong University of Science and Technology
-
Wuhan, Kina, 430079
- Rekrytering
- Hubei Cancer Hospital
-
Wuhan, Kina, 430030
- Rekrytering
- Tongji Hospital Tongji Medical College of Huazhong University of Science and Technology
-
Xiamen, Kina, 361003
- Avslutad
- The first affiliated hospital of xiamen university
-
Xuzhou, Kina, 221000
- Avslutad
- The Affiliated Hospital of Xuzhou Medical University
-
Zhengzhou, Kina, 450008
- Avslutad
- Henan Cancer Hospital
-
Zhuhai, Kina, 519000
- Rekrytering
- The Fifth Affiliated Hospital Sun Yat Sen University
-
-
-
-
-
Zagreb, Kroatien, 10000
- Avslutad
- Klinicki bolnicki centar Zagreb
-
-
-
-
-
Braga, Portugal, 4710 243
- Avslutad
- Uls Braga - Hosp. Braga
-
Lisbon, Portugal, 1649 035
- Avslutad
- Uls Santa Maria - Hosp. Santa Maria
-
Lisbon, Portugal, 1998050
- Rekrytering
- Hosp. Cuf Descobertas
-
Porto, Portugal, 4099-001
- Avslutad
- Uls Santo Antonio - Hosp. Santo Antonio
-
Vila Nova de Gaia, Portugal, 4434 502
- Rekrytering
- Uls Gaia Espinho
-
-
-
-
-
Bucharest, Rumänien, 22328
- Aktiv, inte rekryterande
- Institutul Oncologic Prof Dr Al Trestioreanu Bucuresti
-
-
-
-
-
Belgrade, Serbien, 11000
- Avslutad
- Institute of Oncology and Radiology of Serbia
-
Belgrade, Serbien, 11000
- Avslutad
- Vojnomedicinska Akademija
-
Kamenitz, Serbien, 21204
- Avslutad
- Institute of Oncology of Vojvodina
-
Kragujevac, Serbien, 34000
- Avslutad
- University Clinical Center Kragujevac
-
-
-
-
-
Barakaldo, Spanien, 48903
- Rekrytering
- Hosp. Univ. de Cruces
-
Barcelona, Spanien, 8035
- Rekrytering
- Hosp Univ Vall D Hebron
-
Barcelona, Spanien, 08036
- Avslutad
- Hosp Clinic de Barcelona
-
Jerez de la Frontera, Spanien, 11407
- Rekrytering
- Hosp. de Jerez de La Frontera
-
L'Hospitalet de Llobregat, Spanien, 08908
- Rekrytering
- Instituto Catalan Deoncologia Hospital Duran I Reynals
-
Las Palmas de Gran Canaria, Spanien, 35001
- Avslutad
- Hospitales Universitarios San Roque En Las Palmas de Gran Canaria Centro Oncologico Integral Canario
-
Lugo, Spanien, 27003
- Rekrytering
- Hosp. Univ. Lucus Augusti
-
Madrid, Spanien, 28041
- Rekrytering
- Hosp. Univ. 12 de Octubre
-
Madrid, Spanien, 28007
- Rekrytering
- Hosp. Gral. Univ. Gregorio Maranon
-
Madrid, Spanien, 28040
- Rekrytering
- Hosp Univ Fund Jimenez Diaz
-
Madrid, Spanien, 28050
- Avslutad
- Hosp Univ Hm Sanchinarro
-
Málaga, Spanien, 29010
- Rekrytering
- Hosp Regional Univ de Malaga
-
Pamplona, Spanien, 31008
- Avslutad
- Hosp. de Navarra
-
Sabadell, Spanien, 08208
- Rekrytering
- Hosp.Univ.Parc Tauli
-
Santander, Spanien, 39008
- Rekrytering
- Hosp. Univ. Marques de Valdecilla
-
Seville, Spanien, 41013
- Rekrytering
- Hosp. Virgen Del Rocio
-
Valencia, Spanien, 46014
- Rekrytering
- Hosp. Gral. Univ. Valencia
-
Valencia, Spanien, 46009
- Rekrytering
- Inst. Valenciano de Oncologia
-
Zaragoza, Spanien, 50009
- Rekrytering
- Hosp. Clinico Univ. Lozano Blesa
-
-
-
-
-
Edinburgh, Storbritannien, EH4 2XU
- Rekrytering
- Western General Hospital
-
Glasgow, Storbritannien, G12 0YN
- Rekrytering
- NHS Greater Glasgow and Clyde
-
Guildford, Storbritannien, GU2 7XX
- Rekrytering
- The Royal Surrey County Hospital NHS Foundation Trust
-
London, Storbritannien, SW3 6JJ
- Rekrytering
- The Royal Marsden NHS Trust
-
Newcastle upon Tyne, Storbritannien, NE7 7DN
- Rekrytering
- Newcastle upon Tyne Hospitals NHS Foundation Trust
-
Nottingham, Storbritannien, NG5 1PB
- Rekrytering
- Nottingham City Hospital
-
-
-
-
-
Gothenburg, Sverige, 41345
- Avslutad
- Sahlgrenska Universitetssjukhuset
-
-
-
-
-
Seoul, Sydkorea, 05505
- Rekrytering
- Asan Medical Center
-
Seoul, Sydkorea, 03722
- Rekrytering
- Severance Hospital Yonsei University Health System
-
Seoul, Sydkorea, 06591
- Avslutad
- The Catholic University of Korea Seoul St Mary s Hospital
-
Suwon, Sydkorea, 16247
- Rekrytering
- The Catholic university of Korea, St. Vincent's Hospital
-
-
-
-
-
Bei Qu, Taiwan, 704
- Rekrytering
- National Cheng Kung University Hospital
-
Changhua, Taiwan, 500
- Rekrytering
- Changhua Christian Hospital
-
Keelung, Taiwan, 20442
- Rekrytering
- Chang-Gung Memorial Hospital-Keelung
-
Taichung, Taiwan, 40705
- Rekrytering
- Taichung Veterans General Hospital
-
Taipei, Taiwan, 100
- Rekrytering
- National Taiwan University Hospital
-
-
-
-
-
Olomouc, Tjeckien, 779 00
- Avslutad
- Fakultni nemocnice Olomouc
-
Prague, Tjeckien, 180 81
- Aktiv, inte rekryterande
- Nemocnice Bulovka
-
-
-
-
-
Giessen, Tyskland, 35392
- Rekrytering
- Universitaetsklinikum Giessen und Marburg GmbH
-
Hanover, Tyskland, 30625
- Rekrytering
- Medizinische Hochschule Hannover
-
Jena, Tyskland, 07747
- Avslutad
- Universitatsklinikum Jena
-
München, Tyskland, 81675
- Avslutad
- Klinikum rechts der Isar an der Technischen Universitat Munchen
-
Rostock, Tyskland, 18059
- Avslutad
- Universitaetsmedizin Rostock
-
-
-
-
-
Budapest, Ungern, 1062
- Avslutad
- Eszak Pesti Centrumkorhaz Honvedkorhaz
-
Budapest, Ungern, 1122
- Rekrytering
- Orszagos Onkologiai Intezet
-
Szeged, Ungern, 6720
- Rekrytering
- Szent Gyorgyi Albert Klinikai Kozpont Onkoterapias Klinika
-
-
-
-
-
Graz, Österrike, 8036
- Avslutad
- Medizinische Universitat Graz
-
Innsbruck, Österrike, 6020
- Rekrytering
- Medical University Innsbruck
-
Linz, Österrike, 4010
- Rekrytering
- Ordensklinikum Linz GmbH Barmherzige Schwestern
-
Vienna, Österrike, 1090
- Rekrytering
- Medizinische Universitaet Wien
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
-
Age greater than or equal to (>=) 60 years old
-
Biopsy-confirmed squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx, or supraglottic larynx and a candidate for definitive radiation therapy with or without cetuximab
-
Clinical stage T3-4 NX or T2 N2-3 disease according to the 8th edition of AJCC
-
One primary tumor lesion amendable for intratumoral injection
-
Ineligible to receive platinum-based chemotherapy with radiation (at least one of the following):
- Estimated creatinine clearance >= 30 and less than (<) 50 milliliters/minute (mL/min) (per Cockcroft-Gault equation),
- Grade >= 2 hearing loss or tinnitus,
- Grade >= 2 peripheral neuropathy,
- New York Heart Association Class 3
- Aged 70-74 years old with Geriatric 8 (G8) score less than or equal to (<=) 14 or Aged >= 75 years old
-
Eastern cooperative oncology group (ECOG) performance status 0 to 1
-
Life expectancy >= 6 months
Exclusion Criteria:
- Carcinoma of the nasopharynx, paranasal sinus, salivary gland, or thyroid gland; or non-squamous histology or SCC of unknown primary origin
- Clinical stage T1-2 N0, T2 N1, or M1 disease according to the 8th edition of AJCC
- Loco-regionally recurrent head & neck cancer that has been previously treated with surgery, radiation therapy, and/or chemotherapy
- Prior or concurrent primary malignancy (including second synchronous head & neck cancer) within the last 2 years of informed consent and whose natural history has the potential to interfere with the safety and efficacy assessment of the investigational agent
- Ongoing or active infection requiring treatment with antimicrobial therapy within 2 weeks of randomization
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Behandling
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: Arm A: JNJ-90301900 (NBTXR3)
JNJ-90301900 (NBTXR3), as an intratumoral/intranodal injection, activated by investigator's choice of RT alone or RT in combination with cetuximab. JNJ-90301900 (NBTXR3) is given as a dose of 33% of the Gross Tumor Volume. |
Suspension of inert, crystalline hafnium oxide particles, designed to generate oxygen free radicals to destroy cancer cells after activation by ionizing radiation.
Andra namn:
Solution for infusion
Andra namn:
Intensity-modulated radiation therapy (IMRT): 70 Gray in 35 fractions over a 7-week period. |
|
Aktiv komparator: Arm B: RT alone or RT in combination with cetuximab
Investigator's choice of RT alone or RT in combination with cetuximab. |
Solution for infusion
Andra namn:
Intensity-modulated radiation therapy (IMRT): 70 Gray in 35 fractions over a 7-week period. |
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Progression-free Survival (PFS) Based on Independent Central Review (ICR)
Tidsram: 30 months following first randomized participant
|
PFS is defined as time from randomization to local-regional progression (including recurrence), distant progression, or death from any cause, whichever occurs first. |
30 months following first randomized participant
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Overall Survival (OS)
Tidsram: 48 months following first randomized participant
|
Time from randomization to death from any cause. |
48 months following first randomized participant
|
|
Local-regional control
Tidsram: 48 months following first randomized participant
|
Time to local regional progression: time from randomization to local-regional progression (including recurrence) or death, whichever occurs first. |
48 months following first randomized participant
|
|
Distant control
Tidsram: 48 months following first randomized participant
|
Time to distant progression: time from randomization to distant progression or death, whichever occurs first. |
48 months following first randomized participant
|
|
Quality of Life over time - QLQ H&N35
Tidsram: 48 months following first randomized participant
|
Change from baseline over time in symptoms, function, and health related QOL using the European organisation for research and treatment of cancer (EORTC) questionnaire-head and neck cancer module (QLQ H&N35). |
48 months following first randomized participant
|
|
Quality of Life over time - EQ 5D 5L
Tidsram: 48 months following first randomized participant
|
Change from baseline over time in symptoms, function, and health related QOL using the 5 level EuroQol 5 dimension (EQ 5D 5L) instrument. |
48 months following first randomized participant
|
|
Safety across duration of study - AEs
Tidsram: 48 months following first randomized participant
|
Adverse events (AEs). |
48 months following first randomized participant
|
|
Objective Response Rate (ORR)
Tidsram: 48 months following first randomized participant
|
Rate of complete response (CR)+partial response (PR) [RESIST 1.1]. |
48 months following first randomized participant
|
|
Duration of Overall Response
Tidsram: 48 months following first randomized participant
|
Time from CR or PR to progression of disease, unequivocal clinical progression, or death, whichever occurs first. |
48 months following first randomized participant
|
|
Head and Neck Cancer Specific Event-Free Survival
Tidsram: 48 months following first randomized participant
|
Time from randomization to loco regional progression (including recurrence), distant progression, or head and neck cancer related death, as per RECIST 1.1, whichever occurs first. |
48 months following first randomized participant
|
|
Head and Neck Cancer-Specific Survival
Tidsram: 48 months following first randomized participant
|
Time from randomization to head and neck cancer-related death. |
48 months following first randomized participant
|
Samarbetspartners och utredare
Utredare
- Studierektor: Johnson & Johnson Enterprise Innovation Inc Clinical trial, Johnson & Johnson Enterprise Innovation Inc.
Publikationer och användbara länkar
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Beräknad)
Avslutad studie (Beräknad)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
- Neoplasmer efter plats
- Neoplasmer
- Neoplasmer efter histologisk typ
- Neoplasmer i huvud och hals
- Neoplasmer, körtel och epitel
- Carcinom
- Neoplasmer, skivepitelceller
- Skivepitelcancer i huvud och hals
- Karcinom, skivepitel
- Aminosyror, peptider och proteiner
- Proteiner
- Terapeutik
- Antikroppar, monoklonal, humaniserad
- Antikroppar, monoklonal
- Antikroppar
- Immunglobuliner
- Immunoproteiner
- Blodproteiner
- Serumglobuliner
- Globuliner
- Cetuximab
- Strålbehandling
Andra studie-ID-nummer
- NANORAY-312
- NANORAY-312 (Annan identifierare: Janssen Research & Development, LLC)
- 2024-520386-31-00 (Registeridentifierare: EUCT number)
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .